• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Cystic Fibrosis Therapeutics in Major Developed Market to be Worth $4.0 Billion by 2019

    Written by Vivien Diniz
    |
    Feb. 25, 2016 10:50AM PST

    A report by Radiant Insights indicates that the cystic fibrosis market had a market value of more than USD 695 million in 2012 and is anticipated to rise drastically over the future period in the major 8 developed countries and will surpass USD $4 billion by 2019.

    A report by Radiant Insights indicates that the cystic fibrosis market had a market value of more than USD 695 million in 2012 and is anticipated to rise drastically over the future period in the major 8 developed countries and will surpass USD $4 billion by 2019.
    According to the press release:

    Thus associates to a compounded annual growth rate of more than 30%.

    Click here to view the full press release. 

    cystic fibrosis
    The Conversation (0)

    Go Deeper

    AI Powered
    Researcher in medical lab looking at sample with microscope.

    Oncology Stocks: 8 Biggest NASDAQ Companies in 2026

    Biotech Outlook

    Biotech Outlook

    Latest News

    Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation

    Lexaria Receives USD$2.6 Million Tax Rebate Payment

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES